Pandox AB
STO:PNDX B
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pandox AB
STO:PNDX B
|
SE |
|
F
|
Ferrotec An Hui Technology Development Co Ltd
SZSE:301297
|
CN |
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
CN |
|
Sieyuan Electric Co Ltd
SZSE:002028
|
CN |
|
Jayride Group Ltd
ASX:JAY
|
AU |
|
C
|
Charan Insurance PCL
SET:CHARAN
|
TH |
|
TPI Triunfo Participacoes e Investimentos SA
BOVESPA:TPIS3
|
BR |
|
Balmer Lawrie and Company Ltd
NSE:BALMLAWRIE
|
IN |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PNDX B's stock price target?
Not Available
PNDX B doesn't have any price targets made by Wall Street professionals.
What is Pandox AB's Revenue forecast?
Projected CAGR
4%
For the last 9 years the
compound annual growth rate for
Pandox AB's revenue is
7%.
The projected
CAGR
for the next 3 years is
4%.
What is Pandox AB's Operating Income forecast?
Projected CAGR
8%
For the last 9 years the
compound annual growth rate for
Pandox AB's operating income is
10%.
The projected
CAGR
for the next 3 years is
8%.
What is Pandox AB's Net Income forecast?
Projected CAGR
-1%
For the last 9 years the
compound annual growth rate for
Pandox AB's net income is
4%.
The projected
CAGR
for the next 3 years is
-1%.
